Dr. Barbara Pro MD Medical Oncologist

Dr. Barbara Pro is a medical oncologist in Philadelphia, Pennsylvania and is affiliated with Thomas Jefferson University Hospital. She received her medical degree from Sapienza University of Rome and has been in practice for 26 years. She is one of 19 doctors at Thomas Jefferson University Hospital who specialize in Medical Oncology. She also speaks multiple languages, including Farsi and Spanish.

Are you Dr. Barbara Pro? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: Hematologic

Clinical Interests: Non-Hodgkin Lymphoma, Hodgkin Disease, T-Lymphocytes

Hospital Affiliation

Thomas Jefferson University Hospital
Ranked #17 in Cancer

Education & Medical Training

Mount Sinai School of Medicine
Residency, Internal Medicine, 1994 - 1997

University of Texas at Houston
Fellowship, Medical Oncology, 1997 - 2000

Sapienza University of Rome
Class of 1988

Certifications & Licensure

American Board of Family Medicine
Certified in Family Medicine

American Board of Internal Medicine
Certified in Internal Medicine

WI State Medical License
Active through 2013

Publications & Presentations

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins.
Bollard CM , Gottschalk S , Torrano V , Diouf O , Ku S , Hazrat Y , Carrum G , Ramos C , Fayad L , Shpall EJ , Pro B , Liu H , Wu MF , Lee D , Sheehan AM , Zu Y , Gee AP , Brenner MK , Heslop HE , Rooney CM

Phase I Study of Panobinostat plus Everolimus in Patients with Relapsed or Refractory Lymphoma.
Oki, Y.,Buglio, D.,Fanale, M.,Fayad, L.,Copeland, A.,Romaguera, J.,Kwak, L. W.,Pro, B.,de Castro Faria, S.,Neelapu, S.,Fowler, N.,Hagemeister, F.,Zhang, J.,Zhou, S.,Feng, L.,Younes, A.

Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressi
Hagemeister, F.,Rodriguez, M. A.,Deitcher, S. R.,Younes, A.,Fayad, L.,Goy, A.,Dang, N. H.,Forman, A.,McLaughlin, P.,Medeiros, L. J.,Pro, B.,Romaguera, J.,Samaniego, F.,Silverman, J. A.,Sarris, A.,Cabanillas, F.

See all 17 publications
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.